Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells
|更新时间:2024-04-03
|
Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells
“The latest research has found that Bu Zhong Yi Qi Tang can improve cisplatin resistance in non-small cell lung cancer by inhibiting the Nrf2/ROS pathway, inducing mitochondrial pathway cell apoptosis.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 1, Pages: 95-102(2024)
MU Qirui,LI He,LIU Yuetong,et al.Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(01):95-102.
MU Qirui,LI He,LIU Yuetong,et al.Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(01):95-102. DOI: 10.13422/j.cnki.syfjx.20232025.
Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells